CommercialCoverageMedium impact
Titanium Rib (CPB 0582, reviewed 2025-12-02)
Aetna·Cardiothoracic Surgery, Orthopedics, Pediatrics·Medical Policy
Effective date
Dec 2, 2025
We identified it
Aug 18, 2026
Summary
Aetna's updated Clinical Policy Bulletin 0582 clarifies coverage for vertical expandable prosthetic titanium ribs (VEPTR) as medically necessary for thoracic insufficiency syndrome in skeletally immature patients, while explicitly designating VEPTR as experimental/investigational for scoliosis without thoracic insufficiency syndrome and other off-label indications. Billing teams must ensure claims are submitted only with qualifying diagnoses related to thoracic insufficiency syndrome; claims for scoliosis alone or Poland syndrome will be denied.
Action Required
Immediately: Billing team must implement prior authorization review process for VEPTR procedures. (1) Update billing system to flag all VEPTR claims and require verification that diagnosis codes include ONLY covered conditions: thoracic insufficiency syndrome with flail chest (S22.5), hypoplastic thorax syndrome (Q78.9, Q77.6, Q76.6, Q76.7, Q67.5), rib fusion with scoliosis (M96.5, M41.00-M41.9), or acquired chest deformity (M95.4). (2) DENY all claims that list scoliosis as the sole or primary indication (M41 codes without thoracic insufficiency context), congenital kyphosis (Q76.411-Q76.419), Poland syndrome, or hyper-kyphosis (M40 codes). (3) Educate providers that VEPTR is experimental for early-onset scoliosis, idiopathic infantile scoliosis, and kyphoscoliosis without documented thoracic insufficiency. (4) Add coverage criteria checklist to encounter forms requiring confirmation of patient age (6 months to skeletal maturity), presence of proximal ribs, adequate soft tissue coverage, and adequate bone strength. Failure to apply these restrictions will result in claim denials and potential overpayment recoupment.